National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 2/12/2021 release of VAERS data:

Found 7 cases where Location is Washington and Vaccine is COVID19 and Patient Died

Table

   
AgeCountPercent
44-65 Years342.86%
65-75 Years114.29%
75+ Years342.86%
TOTAL7100%

Case Details

VAERS ID: 921768 (history)  
Form: Version 2.0  
Age: 58.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-01-04
Onset:2021-01-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0140 / 1 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Cardiac arrest, Death, Dizziness, Dyspnoea, Fatigue, Feeling hot, Hot flush, Lethargy, Nausea, Respiratory rate decreased, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Acute pancreatitis (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Respiratory failure (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-04
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: None Known
Diagnostic Lab Data: Autopsy scheduled for 01/07/2021
CDC Split Type:

Write-up: Vaccine received at about 0900 on 01/04/2021 at her place of work, Medical Center, where she was employed as a housekeeper. About one hour after receiving the vaccine she experienced a hot flash, nausea, and feeling like she was going to pass out after she had bent down. Later at about 1500 hours she appeared tired and lethargic, then a short time later, at about 1600 hours, upon arrival to a friends home she complained of feeling hot and having difficulty breathing. She then collapsed, then when medics arrived, she was still breathing slowly then went into cardiac arrest and was unable to be revived.


VAERS ID: 929764 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Male  
Location: Washington  
Vaccinated:2020-12-28
Onset:2020-12-29
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025L20A / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2020-12-29
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Hydrochlorthiazide (by record, not confirmed)
Current Illness:
Preexisting Conditions: Hypertension, sleep apnea, obesity. based on medical record
Allergies: no known allergies recorded in medical record
Diagnostic Lab Data:
CDC Split Type:

Write-up: The patient was found deceased at home about 24 hours after immunization. Date of Death:: 12/29/2020; estimated time of death 6:00pm


VAERS ID: 974172 (history)  
Form: Version 2.0  
Age: 94.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-01-24
Onset:2021-01-25
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1283-WA / 1 LA / -

Administered by: Senior Living       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-25
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: guaiFENesin, aspirin, celexa, Buprenorphine, zinc, vitamin D, voltaren gel, miralax, hydralazine, ascorbic acid, coreg, tramadol, metolazone, melatonin, potassium, gabapentin, senna, magnesium, ocuvite, losartan potassium, doss, vitamin B1
Current Illness: COVID-19 diagnosis 12/29/2020, pneumonia, CHF, depression, rheumatoid arthritis and anemia.
Preexisting Conditions: CHF, acute on chronic anemia, pulmonary hypertension, chronic pain, chronic kidney disease stage 3,
Allergies: lisinopril
Diagnostic Lab Data: none
CDC Split Type:

Write-up: Resident passed away 1/25/2021 at 1048pm after the vaccine was given on 1/24/2021. Resident had been being monitored but death was not expected.


VAERS ID: 998576 (history)  
Form: Version 2.0  
Age: 86.0  
Sex: Male  
Location: Washington  
Vaccinated:2021-01-27
Onset:2021-01-27
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 042L20A / 2 - / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Atelectasis, Blood creatinine increased, Blood culture negative, Blood potassium increased, Blood urine present, Brain natriuretic peptide increased, Cardiac telemetry, Chest X-ray abnormal, Electrocardiogram abnormal, Full blood count normal, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Metabolic function test, Pleural effusion, Protein urine present, Pulmonary oedema, Pyrexia, Respiratory distress, SARS-CoV-2 test negative, Sinus tachycardia, Troponin increased, Urine analysis
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (broad), Cardiac failure (narrow), Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Supraventricular tachyarrhythmias (narrow), Retroperitoneal fibrosis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Chronic kidney disease (broad), Hypersensitivity (broad), Tumour lysis syndrome (narrow), Proteinuria (narrow), Tubulointerstitial diseases (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Dehydration (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-31
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Med List @ time vaccine # 2: PRN acetaminophen Bisacodyl PRN TUMS Clotrimazole Flonase Loratadine Lorazepam Melatonin Bengay Nitrostat Zofran oxycodone Miralax Scheduled: acetaminophen 500 md QID amlodipine 5mg BID Metoprolol 50 mg BID Pra
Current Illness: NSTEMI after COVID vaccine #1
Preexisting Conditions: CAD, CKD4, Hypertension, Anemia, dementia
Allergies: DIPYRIDAMOLE, ERYTHROMYCIN, TERAZOSIN
Diagnostic Lab Data: 1/1/2021 CMP remarkable for Potassium 5.8, creatinine 3.20, HS troponin 2.2, 310 BNP 12.7, CBC unremarkable, UA++ protein 1+ blood, Blood Cx No growth x5 days, COVID RNA rapid (-), 1/2/21 COVID PCR (-), Influenza A+B (-), No EKG, Partial CXR no acute cardio pulmonary process, no pneumonia, Telemetry Strip (12/31 22:00 atrial fib normal rate. 1/27/21 CMP remarkable for potassium 6.1, Serum Creatinine 4.46, BNP 1080, HS troponin 13.2, CBC with diff unremarkable, COVID PCR (-), EKG sinus tachycardia, QRS algorithm, left axis deviation rate 107 borderline criteria arterial infarct, CXR Bilateral + alveolar opacities compatible with pulmonary edema, small (L) pleural effusion, (L) basilar air space likely atelectasis
CDC Split Type:

Write-up: Had acute respiratory failure, dysuria NSTEMI after Dose #1 Lot # 025L20A (Moderna) hospitalized same day 12/31/20 administered @ 1040 back to baseline. 2nd Dose on 1/27/21 0950 Lot as above. Unknown exact onset same day, ED by EMS @ 1745, respiratory distress, febrile 39.4 degrees C BP 150/105 RR 29


VAERS ID: 1002636 (history)  
Form: Version 2.0  
Age: 90.0  
Sex: Female  
Location: Washington  
Vaccinated:2020-12-28
Onset:2021-01-17
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025J20A / 1 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Angiogram, Angiogram cerebral abnormal, Aphasia, Cerebral artery occlusion, Computerised tomogram abnormal, Computerised tomogram head, Death, Fall, Movement disorder, NIH stroke scale score increased, Nervous system disorder, Thrombectomy
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Akathisia (broad), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Accidents and injuries (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-01-23
   Days after onset: 6
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ASA 81 mg, allopurinol, potassium chloride, furosemide, diltiazem, metoprolol, tiotropium, albuterol, diclofenac gel topical
Current Illness: None - had exposure to COVID19 + case on 12/18/2020 but tested negative.
Preexisting Conditions: CHF, HTN, hyperlipidemia, atrial fibrillation, COPD (O2 dependent) , CKD Stage 4, type 2 diabetes (diet controlled).
Allergies: Oxycodone, Percodan, atenolol, PCN VK
Diagnostic Lab Data: CT 1/17/21 (no acute hemorrhage but mild hypodensity of greater than 1/3 of the MCA territory) and CT Angiogram on 1/17/21 ( distal L M1/M2 occulsion).
CDC Split Type:

Write-up: On 1/17/2021 patient woke and began her day as usual, was found down by family member 1 hour later conscious but unable to speak and unable to move her R side. She was admitted to the hospital - Initial NIHSS was 26 and CT imaging showed no acute hemorrhage but mild hypodensity of greater than 1/3 of the MCA territory (TPA not recommended). CTA did show distal L M1/M2 occulsion and she was transferred to larger facility for thrombectomy. Unfortunately the patient had persistent severe neurological deficits after thrombectomy. Was discharged home on hospice care and expired on 1/23/21.


VAERS ID: 1014774 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Male  
Location: Washington  
Vaccinated:2021-01-13
Onset:2021-01-15
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-02-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 025L20A / 1 RA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-15
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Unknown
Preexisting Conditions: None Reported
Allergies: None Reported
Diagnostic Lab Data: Unknown
CDC Split Type:

Write-up: We were informed the patient passed away 2 days after receiving the vaccine. We do not have any details about what happened, we were informed by one of his employees. We have no knowledge that this had anything to do with the vaccination in any way.


VAERS ID: 1019670 (history)  
Form: Version 2.0  
Age: 55.0  
Sex: Male  
Location: Washington  
Vaccinated:2021-01-27
Onset:2021-02-02
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-02-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0140 / 1 - / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3302 / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Alanine aminotransferase increased, Anion gap, Aspartate aminotransferase increased, Asthenia, Bacterial test positive, Base excess, Basophil count increased, Bilirubin urine, Blood albumin decreased, Blood alkaline phosphatase increased, Blood bicarbonate increased, Blood bilirubin normal, Blood calcium decreased, Blood chloride decreased, Blood creatine phosphokinase MB decreased, Blood creatine phosphokinase normal, Blood creatinine increased, Blood glucose increased, Blood lactic acid normal, Blood pH decreased, Blood potassium normal, Blood sodium decreased, Blood sodium normal, Blood urea increased, Blood urea nitrogen/creatinine ratio increased, C-reactive protein normal, Carbon dioxide decreased, Cardiac arrest, Chest X-ray abnormal, Chromaturia, Creatine urine increased, Crystal urine present, Death, Differential white blood cell count normal, Dysuria, Endotracheal intubation, Eosinophil count decreased, Erythema, Fluid overload, Full blood count normal, Globulins decreased, Glomerular filtration rate decreased, Glucose urine absent, Haematocrit normal, Haemoglobin decreased, Hypoperfusion, Hypotension, Immature granulocyte count increased, Influenza virus test negative, Intestinal ischaemia, Lipase, Lung opacity, Lymphocyte count normal, Mean cell haemoglobin concentration decreased, Mean cell haemoglobin normal, Mean cell volume increased, Mean platelet volume normal, Metabolic function test, Metamyelocyte percentage, Monocyte count decreased, Monocyte count normal, Neutrophil count, Neutrophil count normal, Nitrite urine absent, Opiates negative, Oxygen saturation decreased, PCO2 increased, PO2 normal, Platelet count normal, Pleural effusion, Pneumonia aspiration, Pneumonitis, Procalcitonin decreased, Protein total decreased, Protein urine present, Pulse absent, Pyrexia, Red blood cell count decreased, Red blood cell sedimentation rate normal, Red blood cells urine, Red cell distribution width increased, Resuscitation, Rib fracture, SARS-CoV-2 test negative, Small intestinal obstruction, Specific gravity urine normal, Toxicologic test normal, Troponin I normal, Urinary casts, Urinary lipids present, Urinary occult blood positive, Urine analysis, Urine analysis abnormal, Urine analysis normal, Urine ketone body present, Urine leukocyte esterase, Urobilinogen urine, Vomiting, White blood cell count normal, White blood cells urine positive, pH urine normal
SMQs:, Torsade de pointes/QT prolongation (broad), Rhabdomyolysis/myopathy (broad), Acute renal failure (broad), Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (narrow), Acute pancreatitis (broad), Angioedema (broad), Haematopoietic erythropenia (narrow), Haematopoietic leukopenia (narrow), Lactic acidosis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (narrow), Hyperglycaemia/new onset diabetes mellitus (narrow), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Gastrointestinal obstruction (narrow), Acute central respiratory depression (broad), Biliary system related investigations, signs and symptoms (broad), Guillain-Barre syndrome (broad), Accidents and injuries (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hyponatraemia/SIADH (narrow), Ischaemic colitis (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (narrow), Osteoporosis/osteopenia (broad), Chronic kidney disease (broad), Hypersensitivity (broad), Tumour lysis syndrome (narrow), Proteinuria (narrow), Tubulointerstitial diseases (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Dehydration (broad), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-04
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Cerebral Palsy, Anxiety, Crohns, Bipolar, GERD, Nutrition deficiency, Iron deficiency
Allergies: lactose
Diagnostic Lab Data: 2/2/2021- CDC, CMP, Lipase, UA, CXR. COVID negative, Influenza Negative. WBC 8.2, HCT 48.2, HGB 16.3, CRP 4.9, NA 135, K+ 4.0, CHL 94, Bicarb 33, BUN 29, Creatinine 0.8, Glucose 145, Alkaline Phosphatase 106, Lipase 24. UA negative. 2/4/2021- 02/04 02/04 02/04 2145 2039 2039 Blood Gas VBG pH (7.31 - 7.41) 6.99 VBG pCO2 (40 - 50 mmHg) 73 VBG pO2 (40 - 50 mmHg) 81 VBG HCO3 (22.0 - 26.00 mmol/L) 17.7 VBG O2 Sat (Meas) (%) 85.8 VBG Base Excess (-2 TO 3 mmol/L) -14.9 VBG Lactic Acid (0.5 - 2.2 mmol/L) 10.1 Chemistry Sodium (135 - 148 mmol/L) 133 Potassium (3.6 - 5.2 mmol/L) 4.2 Chloride (98 - 107 mmol/L) 101 Carbon Dioxide (21 - 32 mmol/L) 18 Anion Gap (mmol/L) 14 BUN (7 - 25 mg/dL) 40 Creatinine (0.7 - 1.5 mg/dL) 1.4 Estimated GFR ($g60) 56 BUN/Creatinine Ratio 28.6 Glucose (70 - 110 mg/dL) 212 Calcium (8.4 - 10.2 mg/dL) 7.4 Total Bilirubin (0.1 - 1.5 mg/dL) 0.4 AST (5 - 40 U/L) 41 ALT (7 - 52 U/L) 40 Alkaline Phosphatase (34 - 104 U/L) 112 Creatine Kinase (35 - 232 U/L) 95 CK-MB (CK-2) (0.6 - 6.3 ng/mL) 2.8 Troponin I (<=0.03 ng/mL) 0.05 C-Reactive Prot, Quant (0.1 - 0.3 mg/dL) 5.7 Serum Total Protein (6.0 - 8.3 g/dL) 4.3 Albumin (3.5 - 5.0 g/dL) 2.6 Globulin (g/dL) 1.7 Albumin/Globulin Ratio 1.5 Procalcitonin (< 0.1 ng/mL) 0.7 Hematology WBC (4.0 - 11.0 K/uL) 6.9 RBC (4.30 - 5.70 M/uL) 4.39 Hgb (13.0 - 17.4 g/dL) 13.4 Hct (39.0 - 52.2 %) 42.8 MCV (80 - 100 fL) 98 MCH (25.0 - 35.0 pg) 31 MCHC (31 - 36 g/dL) 31 RDW Coeff of Var (11.0 - 16.0 %) 14.6 Plt Count (150 - 450 K/uL) 239 MPV (9.4 - 12.4 fL) 9.5 Immature Gran % (Auto) (0.1 - 0.3 %) 13.8 Neut % (Auto) (37.0 - 80.0 %) 56.2 Lymph % (Auto) (10.0 - 50.0 %) 21.8 Mono % (Auto) (0.0 - 12.0 %) 4.9 Eos % (Auto) (0.0 - 5.0 %) 0.6 Baso % (Auto) (0.0 - 3.0 %) 2.7 Immature Gran # (Auto) (0.01 - 0.03 K/uL) 0.96 Absolute Neuts (auto) (2.00 - 8.00 K/uL) 3.90 Absolute Lymphs (auto) (1.00 - 5.00 K/uL) 1.51 Absolute Monos (auto) (0.00 - 1.20 K/uL) 0.34 Absolute Eos (auto) (0.00 - 0.50 K/uL) 0.04 Absolute Basos (auto) (0.00 - 0.30 K/uL) 0.19 Total Counted (CELLS) 100 Neutrophils % (Manual) (37 - 80 %) 41 Band Neutrophils % (< 6 %) 12 Lymphocytes % (Manual) (10 - 50 %) 37 Monocytes % (Manual) (0 - 12 %) 8 Eosinophils % (Manual) (1 - 7 %) 0 Basophils % (Manual) (<4 %) 0 Metamyelocytes % (%) 2 Nucl RBC Rel Cnt (Man) (/100 WBC) 2 ESR (0 - 20 mm/hr) 4 Toxicology Urine Opiates Screen (NEG) NEG Ur Oxycodone Screen (NEG) NEG Urine Methadone Screen (NEG) NEG Ur Propoxyphene Screen (NEG) NEG Ur Barbiturates Screen (NEG) NEG U Tricyclic Antidepress (NEG) NEG Ur Phencyclidine Scrn (NEG) NEG Ur Amphetamines Screen (NEG) NEG U Methamphetamines Scrn (NEG) NEG U Benzodiazepines Scrn (NEG) NEG Urine Cocaine Screen (NEG) NEG U Marijuana (THC) Screen (NEG) NEG Urines Urine Source URINE - FOLEY CATH Urine Color YELLOW Urine Appearance (CLEAR/HAZY) TURBID Urine pH (5 - 9) 5.5 Ur Specific Gravity (1.005 - 1.030) $g=1.030 Urine Protein (NEG/TRACE mg/dL) $g=300 Urine Glucose (UA) (NEG mg/dL) NEGATIVE Urine Ketones (NEG mg/dL) 15 Urine Occult Blood (NEG) LARGE Urine Nitrite (NEG) NEGATIVE Urine Bilirubin (NEG) MODERATE Urine Urobilinogen (0.2 - 1.0 E.U./dL) 0.2 Ur Leukocyte Esterase (NEG) NEGATIVE Urine RBC (<3 /HPF) 11-20 Urine WBC (<6 /HPF) $g100 Ur Squamous Epith Cells (/HPF) RARE Amorphous Crystals (/HPF) MOD Urine Bacteria (/HPF) FEW Hyaline Casts (NONE SEEN /LPF) FEW Fine Granular Casts (NONE SEEN /LPF) FEW Urine Mucus (/LPH) FEW Ur Oval Fat Bodies (NONE SEEN /HPF) FEW Vol Urine Centrifuged (mL) 5 U Random Total Protein (mg/dL) 446 U Rand Prot/Creat Ratio (LT 0.2 RATIO) ND Urine Creatinine (mg/dL) 94
CDC Split Type:

Write-up: 2/2/2021- seen in Ed with c/o intermittent fever following 2nd dose. Redness to bilateral upper extremities, c/o some pain with urination, weak. V/S stable, afebrile in ED. Assess for infection. No significant abnormal labs (see below), hydrated and discharged. 2/4/2021- arrived in ED with c/o vomiting, seen earlier by PCP that day labs drawn. Shortly after arriving in the ED copious amouts of emesis noted, the patient went into full cardiac arrest and CPR was started. -Please see HPI above, in addition after intubation the patient coded again. More epinephrine and lidocaine were given. CPR was resumed. We did obtain ROSC and targeted temperature management was pursued. He is placed on a lidocaine drip and a right femoral central line was placed by myself. At this time, norepinephrine drip was initiated given his continued hypotension. Post intubation chest x-ray suggests possible abdominal pathology and once the patient was stabilized further, he was sent to the CT scanner where CT head without IV contrast and CT chest, abdomen and pelvis with IV contrast was obtained. He did lose pulses once in the radiology suite. This was brief. IV fluids were initiated and he received over 2 L of crystalloid therapy. He continued to be hypotensive in the emergency department and vasopressin was added. He also had a single dose of Neo-Synephrine and IV push fashion to help bring his blood pressure up. CT scan reveals probable bilateral aspiration pneumonia/pneumonitis and dilated loops of small bowel without a transition point and pneumatosis involving loops in the left upper quadrant. I did try to initiate consult with critical care and possible transfer, however he continued to be unstable and coded requiring CPR multiple times. He was given IV bicarbonate given his prolonged CPR state and pH. Ultimately, the family decided to make the patient comfort measures only given his critical illness. Shortly after making this decision he did pass away in the emergency department. RADIOLOGY DIAGNOSTIC - CHEST PORTABLE 02/04 2051 *** Report Impression - Status: SIGNED Entered: 02/04/2021 2059 IMPRESSION: 1. Findings highly suspicious for portal venous gas which can be seen in the setting of bowel ischemia. Consider CT for further evaluation and/or surgical consultation. 2. Endotracheal tube 3.7 cm above the carina. 3. Low lung volumes with mild patchy perihilar opacities. Final Report Signed by: M.D., Sign Date/Time: 02/04/2021 8:55 PM Impression By: MD CT SCAN - CT HEAD WO 02/04 2140 *** Report Impression - Status: SIGNED Entered: 02/04/2021 2200 IMPRESSION: Negative for acute intracranial process. No evidence of mass effect, acute hemorrhage or definite acute cortical infarct. Final Report Signed by: M.D., Sign Date/Time: 02/04/2021 9:57 PM Impression By: - MD CT SCAN - CT CHEST/ABD/PELVIS W 02/04 2140 *** Report Impression - Status: SIGNED Entered: 02/04/2021 2214 IMPRESSION: 1. Ill-defined patchy opacities within the bilateral upper lobes, right middle lobe, in consolidative opacities within bilateral lower lobes which could represent aspiration, and/or multifocal pneumonia. 2. Small right trace left pleural effusions. 3. Diffusely dilated small bowel without a transition point and mucosal hyperenhancement involving the colon with areas of pneumatosis involving loops of small bowel within the left upper quadrant and portal venous air consistent with hypoperfusion complex. There is a small caliber appearance of the aorta and a flattened appearance of the IVC is well. 4. Intravascular air within the IVC and bilateral iliac veins could be secondary to right femoral central lying injection. 5. Somewhat abnormal enhancement pattern of the kidneys with hypoenhancement of the medullary pyramids which may suggest hypoperfusion injury as well. 6. Probable nondisplaced rib fractures on the right at ribs 2 through


New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&VAX=COVID19&DIED=Yes&STATE=WA


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166